Sonoma Pharmaceuticals, Inc. (SNOA)
Sonoma Pharmaceuticals is a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological conditions and advanced tissue care. The company’s products, which are sold throughout the United States and internationally, have improved outcomes for more than five million patients globally by reducing infections, itch, pain, scarring and harmful inflammatory responses. The company’s headquarters are in Petaluma, California, with manufacturing operations in the United States and Latin America. European marketing and sales are headquartered in Roermond, Netherlands.
Description
Sonoma Pharmaceuticals is a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological conditions and advanced tissue care. The company’s products, which are sold throughout the United States and internationally, have improved outcomes for more than five million patients globally by reducing infections, itch, pain, scarring and harmful inflammatory responses. The company’s headquarters are in Petaluma, California, with manufacturing operations in the United States and Latin America. European marketing and sales are headquartered in Roermond, Netherlands.
Contact Information
1129 North McDowell Blvd
Petaluma, CA 94954
Website: http://www.oculusis.com
Phone: (707) 283-0550
Financial Reporting/Disclosure
Reporting Status : U.S. Reporting: SEC Reporting
Latest Report : Jun 30, 2016 10-Q
CIK : 0001367083
Fiscal Year End : Not Available
OTC Marketplace : Not Available
Profile Data
SIC – Industry Classification : Not Available
Incorporated In : CA, USA
Year of Inc. : Not Available
Employees : Not Available
Company Directors
Not Available
Service Providers
Accounting/Auditing Firm
Marcum LLP
750 Third Ave
11th Floor
New York, NY, 10017
United States
Legal Counsel
Not Available
Investor Relations Firm
Not Available